Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation

Journal of Endocrinology

Volumn 183, Issue 3, 2004, Pages 585-594

  Nagpal, Madan L ^a,b   Chen, Yue ^a,b,c   Lin, Tu ^a,b  

^a WJB Dorn VA Medical Center   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c SHANTOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; COMPLEMENTARY DNA; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; PROGESTERONE; SOMATOMEDIN C; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; LEYDIG CELL TUMOR; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEROIDOGENESIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINES, CXC; GENE EXPRESSION; LEYDIG CELL TUMOR; MALE; MICE; PHOSPHOPROTEINS; PROGESTERONE; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTICULAR NEOPLASMS; TRANSFECTION;

EID: 11244347772     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05795     Document Type: Article

References (42)

1. Angiolillo A, Sgadari C, Taub D, Liao F, Farber J, Maheshwari S, Kleinman H, Reaman G & Tosato G 1995 Human interferon-inducible protein-10 is a potent inhibitor of angiogenesis in vivo. Journal of Experimental Medicine 182 185-192.
2. Ascoli M 1981 Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology 108 88-95.
3. Booth V, Keizer DW, Kamphuis MB, Clark-Lewis I & Sykes BD 2002 The CXCR3 binding chemokines IP-10/CXCL10: structure and receptor interactions. Biochemistry 41 10418-10425.
4. Bustin SA 2002 Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of Molecular Endocrinology 25 169-193.
5. Chen Y, Nagpal ML & Lin T 2003 Expression and regulation of glucose transporter 8 in rat Leydig cells. Journal of Endocrinology 179 63-72.
6. Dwinell MB, Eckmann L, Leopard JD, Varki NM & Kagnoff MF 1999 Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 117 359-367.
7. Farber JM 1997 Mig and IP-10 CXC: chemokines that target lymphocytes. Journal of Leukocyte Biology 61 246-257.
8. Feldman AL, Friedl J, Lans TE, Libutti SK, Lorang D, Miller MS, Turner EM, Hewitt SM & Alexander HR 2002 Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts. International Journal of Cancer 99 149-153.
9. Gangur V, Birmingham NP & Thanesvorakul S 2002 Chemokines in health and disease. Veterinary Immunology and Immunopathology 86 127-136.
10. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W & Groopman JE 1998 The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G protein-coupled CXCR4 receptor and activates multiple signal transduction pathways. Journal of Biological Chemistry 273 23169-23175.
11. Goffic RL, Mouchel T, Aubry F, Patard JJ, Ruffault A, Jegou B & Samson M 2002 Production of the chemokines monocyte chemotactic protein-1, regulated on activation normal T cell expressed and secreted protein, growth-related oncogene, and interferon-γ-inducible protein-10 is induced by the Sandai virus in human and rat testicular cells. Endocrinology 143 1434-1440.
12. Goldberg-Bittman L, Neumark E, Sagi-Assif O, Azenshtein E, Meshel T, Witz IP & Ba-Baruch A 2004 The expression of the chemokine receptor CXCR3 and its ligand CXCL10 in human breast adenocarcinoma cell lines. Immunology Letters 92 171-178.
13. Hu J, You S, Li W, Wang D, Nagpal ML, Mi Y, Liang P & Lin T 1998 Expression and regulation of interferon-γ-inducible protein-10 (IP-10) gene in rat Leydig cells. Endocrinology 139 3637-3645.
14. Kanegane C, Sgadari G, Kanegane H, Teruya-Feldstein J, Yao L, Gupta G, Farber JM, Lio F, Lio L & Tosato G 1998 Contribution of the CXC chemokines IP-10 and MIG to the antitumor effects of IL-12. Journal of Leukocyte Biology 64 384-392.
15. Kozak M 1991 Structural features in eukaryotic mRNAs that modulate the initiation of translation. Journal of Biological Chemistry 266 19867-19870.
16. Lisignoli G, Toneguzzi S, Grassi F, Piacentini A, Tschon M, Cristino S, Gualtieri G & Facchini A 2002 Different chemokines are expressed in human arthritic bone biopsies: IFN-gamma and IL-6 differently modulate IL-8, MCP-1 and RANTES production by arthritic osteoblasts. Cytokine 20 231-238.
17. Luster AD 1998 Chemokines: chemotactic cytokines that mediate inflammation. New England Journal of Medicine 338 436-445.
18. Luster AD, Greenbergi SM & Leder P 1995 The IP-10 chemokine binds to a specific cell surface heparin sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. Journal of Experimental Medicine 182 219-231.
19. Mamchaoui K, Makhloufi Y & Saumon G 2002 Glucose transporter gene expression in freshly isolated and cultured rat pneumocytes. Acta Physiologica Scandinavica 175 19-24.
20. Moser B & Loetscher P 2001 Lymphocyte traffic control by chemokines. Nature Immunology 2 123-128.
21. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ & Power CA 2000 International Union of Pharmacology. XXII. Nomenclature for chemokines receptors. Pharmacological Reviews 52 145-176.
22. Narumi S, Wyner LM, Stoler MH, Tannenbaum CS & Hamilton TA 1992 Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon-γ. Journal of Leukocyte Biology 32 27-33.
23. Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL & Pollak M 2003 In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor-I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Research 61 6276-6280.
24. Ohmori Y & Hamilton TA 1990 A macrophage LPS-inducible early gene encodes the murine homologue of IP-10. Biochemical and Biophysical Research Communications 168 1261-1267.
25. Ohmori Y & Hamilton TA 1995 The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. Journal of Immunology 154 5235-5243.
26. Ohmori Y, Wyner L, Narumi S, Armstrong D, Stoler M & Hamilton TA 1993 Tumor necrosis factor-α induces cell type and tissue-specific expression of chemotractant cytokines in vivo. American Journal of Pathology 142 861-870.
27. Olney RC, Mougey EB, Wang J, Shulman DI & Sylvester JE 2002 Using real-time, quantitative PCR for rapid genotyping of the steroid 21-hydroxylase gene in a north Florida population. Journal of Clinical Endocrinology and Metabolism 87 735-741.
28. Palmer K, Hitt M, Emtage PCR, Gyorffy S & Gauldie J 2001 Combined CXC chemokines and interleukin-12 gene transfer enhances antitumor immunity. Gene Therapy 8 282-290.
29. Pind S, Slominski E, Mauthe J, Pearlman K, Swoboda KJ, Wilkins JA, Sauder P & Natowicz MR 2002 V490 M, a common mutation in 3-phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme. Journal of Biological Chemistry 277 7136-7148.
30. Risberg B, Davidson B, Dong HP, Nesland JM & Berner A 2000 Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings. Journal of Clinical Pathology 53 513-517.
31. Romagnani P, Beltrami C, Annunziato F, Lasgai L, Luconi M, Galli G, Cosmi L, Maggi E, Salvadori M, Pupilli C & Serio M 1999 Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. Journal of the American Society of Nephrology 10 2518-2526.
32. Sgadari C, Angiolillo AL, Cherney BW, Pike SE, Farber JM, Koniaris LG, Vanguri P, Burd PR, Sheikh N, Gupta G, Teruya-Feldstein J & Tosato G 1996 Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. PNAS 93 13791-13796.
33. Soejima K & Rollins BJ 2001 A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. Journal of Immunology 167 6576-6582.
34. Tamaru M, Tominaga Y, Yatsunami K & Narumi S 1998 Cloning of the murine interferon-inducible protein 10 (IP-10) receptor and its specific expression in lymphoid organs. Biochemical and Biophysical Research Communications 25 41-48.
35. Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM & Hamilton TA. 1998 The CXC chemokines IP-10 and Mig are necessary for IL-12 mediated regression of mouse RENCA tumor. Journal of Immunology 161 927-932.
36. Vanguri P & Farber JM 1990 Identification of CRG-2, an interferon-inducible mRNA predicted to encode a murine monokine. Journal of Biological Chemistry 265 15049-15057.
37. Wang X, Yue TL, Ohlstein EH, Sung CP & Feuerstein GZ 1996 Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. Journal of Biological Chemistry 27 24286-24293.
38. Wang X, Li X, Schmidt DB, Foley JJ, Barone FC, Ames RS & Sarau HM 2000 Identification and molecular characterization of rat CXCR3 receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. Molecular Pharmacology 57 1190-1198.
39. Yang F, Johnson BJ, White ME, Hathaway MR & Dayton WR 1999 Effect of insulin-like growth factor (IGF-I) and Des (1-3)IGF-I on the level of IGF binding protein-3 and IGF binding protein-3 mRNA in cultured porcine embryonic muscle cells. Journal of Cellular Physiology 178 227-234.
40. Zang XP, Lerner MR, Brackett DJ & Pento JT 2000 Antisense KGF-induced gene expression in MCF-7 cells using cDNA expression arrays. Breast Cancer Research and Treatment 64 110.
41. Zang XP, Lerner MR, Dunn T, Brackett DJ & Pento JT 2003 Antisense K GFR oligonucleotide inhibition of KGF-induced motility in breast cancer cells. Anticancer Research 23 4913-4920.
42. Zella D, Barabitskaja O, Casareto L, Romerio F, Secchiero P, Reitz MS Jr, Gallo RC & Weichoid FF 1999 Recombinant IFN-α (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells. Journal of Immunology 163 3169-3175.